GIPR and obesity due to melanocortin 4 receptor deficiency: However, how GIPR inhibition protects from obesity and associated insulin resistance remains puzzling, and may include increased lipid utilization [804], decreased intestinal nutrient uptake [1023], decreased food intake [805,1008], and/or increased energy expenditure [803,805].